Anti-HIV Drugs II Flashcards
Administered orally. Most have low systemic bioavailability
Protease inhibitors
Protease inhibitors are metabolized by
CYP3A4
Many drug interactions tied to interactions of PIs with
P450s
Inhibits CYP3A4 and causes PIs to increase
Antifungal ketoconazole
Causes CYP induction resulting in decrease of PIs
Rifampin
The newest protease inhibitor, which is active against some HIV isolates that have become resistant to other PIs
Darunavir
Highly bound by plasma proteins
-Inhibitor and substrate of CYP3A
Darunavir
Flexibility in dosing is lost with fixed dose combination drugs. However, this is often compensated by ease of use and better
Compliance
Emtricitabine/tenofovir disoproxil =
Truvada
Emtricitabine/tenofovir alafenamide =
Descovy
Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil =
Stribild
Elvitegravir/cobicistat/emtricitabine,/ tenofovir alafenamide =
Genvoya
Dolutegravir/abacavir/lamivudine =
Triumeq
Bictegravir/emtricatibine/tenofovir alafenamide =
Biktarvy
Now recommended for all HIV-infected individuals, regardless of their viral load or CD4 count
Antiretroviral Therapy (ART)